Blue Cell Therapeutics ApS: Financial statements 2024
CVR: 39981610
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Blue Cell Therapeutics ApS (CVR 39981610) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -3,052,648 and a net result of DKK -15,189,850 compared with DKK -15,288,373 the year before. Equity in the 2024 report amounted to DKK 13,094,431. The solvency ratio was 92.7%. The company had 12 employees in the financial year.
- Gross Profit
- DKK -3,052,648
- Profit/Loss
- DKK -15,189,850
- Equity
- DKK 13,094,431
- Total Assets
- DKK 14,124,454
- Employees
- 12
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -3.1M | -15.2M | 13.1M | 12 |
| 2023 | - | -742K | -15.3M | 8.4M | 14 |
| 2022 | - | 852K | -12.6M | 9.9M | 12 |
| 2021 | - | -844K | -14.2M | 12.5M | 7 |
| 2020 | - | -2.9M | -14M | 9.8M | 2 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of December 31, 2024, Sebastian Wehle has left the board of directors of Blue Cell Therapeutics ApS.
Blue Cell Therapeutics ApS has published its annual report for 2023. Gross profit came to DKK -741,530, and the net result was DKK -15,288,373.
As of April 11, 2024, Anders Vadsholt has joined the board of directors of Blue Cell Therapeutics ApS.
As of April 11, 2024, Sebastian Wehle has joined the board of directors of Blue Cell Therapeutics ApS.
About Blue Cell Therapeutics ApS
Blue Cell Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Regenerative Therapeutics IVS. The management consists of Søren Paludan Sheikh. The board consists of Olav Hellebø (chair), Anella Rogaczewski, Michael Ulveman and Ole Vahlgren. The company is owned by ANDRÉ ROGACZEWSKI HOLDING II ApS and SPSheikh Holding ApS. The company has 10 employees (2026). In 2025, the company reported a gross profit of DKK -5,780,568 and a net result of DKK -21,221,120 compared with DKK -15,189,850 the year before. Equity in the 2025 report amounted to DKK -8,126,690.